Summit Therapeutics appoints Manmeet Soni as COO

Summit Therapeutics announced that Manmeet Soni has been appointed as the company’s COO, effective immediately. Soni will remain a member of the company’s board of directors. Soni has over 20 years of financial and operational leadership experience and joins Summit from Reata Pharmaceuticals, where he was president, COO & CFO. In conjunction with his appointment as COO, Soni is also purchasing shares of the company worth $5M via a private placement. In his role as COO, Soni will be responsible for all commercial activities, finance, manufacturing, legal, information technology, and human resources. Also, Summit announced that, effective immediately, the following elevated appointments have been made: Dave Gancarz as chief business and strategy officer. Urte Gayko as chief regulatory, quality and pharmacovigilance officer. Fong Clow as chief biometrics officer Allen Yang as chief medical officer.